Bruker Corporation (BRKR) stock is soaring 5.09% in Tuesday's trading session, buoyed by a wave of positive analyst actions following the company's third-quarter earnings report. The scientific instruments manufacturer has caught the attention of Wall Street, with several firms raising their price targets for the stock.

Leading the pack, Barclays maintained its Overweight rating on Bruker and raised its price target to $45 from $40. Analyst Luke Sergott from Barclays reaffirmed a Buy rating on the stock, signaling continued confidence in the company's prospects. Other notable upgrades came from TD Cowen, which increased its target to $42 from $40, and UBS, which lifted its projection to $43 from $40.

The surge in analyst optimism appears to be driven by Bruker's strong performance in the third quarter. While specific details of the earnings report were not provided, the collective upward revision of price targets suggests that the company likely exceeded expectations or provided a positive outlook. Investors are responding favorably to these developments, as evidenced by the significant stock price increase in intraday trading.